References and Notes
1a Reggelin M.
Kuehl J.
Kaiser JP.
Buehle P.
Synthesis
2006,
2224
1b Rajender A.
Gais H.-J.
Org. Lett.
2007,
9:
579
1c Adrien A.
Gais H.-J.
Koehler F.
Runsink J.
Raabe G.
Org. Lett.
2007,
9:
2155
2a Bolm C.
Müller D.
Dalhoff C.
Hackenberger CPR.
Weinhold E.
Bioorg. Med. Chem. Lett.
2003,
13:
3207
2b Cho GY.
Okamura H.
Bolm C.
J. Org. Chem.
2005,
70:
2346 and references therein
3a Harmata M.
Chem. Abstr.
2003,
16:
660
3b Okamura H.
Bolm C.
Chem. Lett.
2004,
33:
482
4a Johnson CR.
Acc. Chem. Res.
1973,
6:
341
4b Pyne SG.
Sulfur Rep.
1992,
12:
57
4c Reggelin M.
Zur C.
Synthesis
2000,
1
4d Bolm C. In
Asymmetric Synthesis with Chemical and Biological Methods
Enders D.
Jäger K.-E.
Wiley-VCH;
Weinheim:
2007.
p.149
5a Luecking U, Krüger M, Jautelat R, and Siemeister G. inventors; WO 037800 A1.
; Schering AG
5b Luecking U, Siemeister G, and Jautelat R. inventors; WO 099974 A1.
; Schering AG
5c Luecking U, Nguyen D, von Bonin A, von Ahsen O, Krueger M, Briem H, Kettschau H, Prien O, Mengel A, Krolikiewicz K, Boemer U, Bothe U, and Hartung I. inventors; WO 071455 A1.
; Schering AG
5d Luecking U. inventors; EP 1 710 246 A1.
; Schering AG
5e Luecking U, Bader B, and Siemeister G. inventors; EP 1 803 723 A1.
; Bayer Schering Pharma
5f Shetty SJ, Patel GD, Lohray BB, Lohray VB, Chakrabarti G, Chatterjee A, Jain MJ, and Patel PR. inventors; WO 077574 A2.
; Cadila Healthcare Limited
5g Zhu Y, Rogers RB, and Huang YX. inventors; US 228027 A1.
; Dow Agroscience
5h Jeanguenat A, and O’Sullivan AC. inventors; WO 032462 A1.
; Syngenta
5i Jeanguenat A, and O’Sullivan AC. inventors; WO 061200 A1.
; Syngenta
5j Plant A, Boehmer JE, and Peace AL. inventors; WO 037945 A1.
; Syngenta
5k Kajita S, Ohmura H, Akashi M, Kojima S, Satoh A, and Tomida K. inventors; WO 052849.
; Nippon Soda Co., Ltd
6 Garcia Mancheño O.
Bolm C.
Org. Lett.
2006,
8:
2349
7 Garcia Mancheño O.
Bistri O.
Bolm C.
Org. Lett.
2007,
9:
3809
8a Butler RN. In
Comprehensive Heterocyclic Chemistry
Vol. 4:
Katritzky AR.
Rees CW.
Scriven EFV.
Pergamon;
Oxford UK:
1996.
p.121
8b Yoo EJ.
Ahlquist M.
Kim SH.
Bae I.
Fokin VV.
Sharpless KB.
Chang S.
Angew. Chem. Int. Ed.
2007,
46:
1730
8c Bock VD.
Hiemstra H.
van Maarseveen JH.
Eur. J. Org. Chem.
2006,
51
8d Lutz JF.
Angew. Chem. Int. Ed.
2007,
46:
1018
9 Sklute G.
Bolm C.
Marek I.
Org. Lett.
2007,
9:
1259
10a Lacôte E.
Amatore M.
Fensterbank L.
Malacria M.
Synlett
2002,
116
10b Leca D.
Song K.
Amatore M.
Fensterbank L.
Lacote E.
Malacria M.
Chem. Eur. J.
2004,
10:
906
11a Okamura H.
Bolm C.
Org. Lett.
2004,
6:
1305
11b Cho GY.
Bolm C.
Org. Lett.
2005,
7:
4983
11c Cho GY.
Bolm C.
Tetrahedron Lett.
2005,
46:
8007
11d Refs 6 and 7.
12 In the reactions reported here, racemic sulfoximines were used.
13 The interactions between the benzylic hydrogens and the hydrogens of the alkyl or alkoxy chain in the 1 H-NOESY spectra also confirmed the molecular structures of triazole derivatives 3b -e ,g ,h . Although present in the crude product mixtures, the other regioisomers (triazoles 5 ) could never be obtained in pure form (Figure
[1
Figure 1
14
General Procedure for the Cycloaddition Reaction Under vigorous stirring a mixture of NaN3 (12 equiv) and the corresponding bromide (15 equiv) was heated to reflux in H2 O (0.7 M) for 1 h. Then, a solution of sulfoximine 4 (1 equiv) in CH2 Cl2 (0.08 M) was added dropwise. After 3 h at 100 °C under reflux and stirring, the product was extracted with CH2 Cl2 and purified by flash column chromatography. As representative example, the analytical data for 1-benzyl-5-butyl-4-(N -tosyl)-(4-methylphenylsulfonimidoyl)-1H -1,2,3-triazole (3a ) obtained from the reaction of sulfoximine 4a with benzyl azide are given. Colorless oil (68%); chromatography: EtOAc-pentane (1:3). 1 H NMR (400 MHz, CDCl3 ): δ = 0.79 (t, J = 7.0 Hz, 3 H), 1.21-1.29 (m, 4 H), 2.37 (s, 3 H), 2.41 (s, 3 H), 2.76-2.85 (m, 1 H), 2.93-3.02 (m, 1 H), 5.44 (d, J = 15.5 Hz, 1 H), 5.49 (d, J = 15.5 Hz, 1 H), 7.14-7.18 (m, 2 H), 7.20 (d, J = 8.0 Hz, 2 H), 7.31-7.35 (m, 5 H), 7.80 (d, J = 8.3 Hz, 2 H), 7.98 (d, J = 8.5 Hz, 2 H). 13 C NMR (100 MHz, CDCl3 ): δ = 13.6 (CH3 ), 21.5 (CH3 ), 21.7 (CH3 ), 22.7 (CH2 ), 23.0 (CH2 ), 30.5 (CH2 ), 52.5 (CH2 ), 126.5 (CH), 127.2 (CH), 128.2 (CH), 128.7 (CH), 129.0 (2 × CH), 129.9 (CH), 133.5 (C), 135.2 (C), 140.4 (C), 141.4 (C), 141.9 (C), 142.6 (C), 145.4 (C). IR (CHCl3 ): ν = 2959 (m), 1454 (m), 1318 (m), 1243 (m), 1096 (s), 1018 (m), 757 (s), 540 (m). MS (CI): m/z (relative intensity) = 523 (6) [M + H]+ . Anal. Calcd for C27 H30 N4 S2 O3 : C, 62.04; H, 5.79; N, 10.72. Found: C, 62.06; H, 5.81; N, 11.14.
